149 results on '"Cepika, Alma"'
Search Results
2. A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection
3. Therapeutics and Diagnostics Discovery
4. Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia
5. Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy
6. Correction to: Therapeutics and Diagnostics Discovery
7. Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells
8. Enhanced Immune Reconstitution and Reduced GvHD Risk with T-allo10 Infusion Post Aβdepleted-HSCT in Pediatric and Young Adult Patients with Hematologic Malignancies
9. Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
10. Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape
11. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
12. Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition.
13. Data from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
14. Table S4 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
15. SATB1ss Chromatin Loops Regulate Megakaryocyte/Erythroid Progenitor Expansion by Facilitating HSP70 and GATA1 Induction
16. Toll-like receptors in pathogenesis of systemic lupus erythematosus
17. T-allo10 Infusion after αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD
18. Systems approaches to human autoimmune diseases
19. Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines
20. Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment
21. Phase 1/1b Study of T-allo10 Infusion after HLA-Partially Matched αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Preliminary Results
22. Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients
23. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency
24. BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation
25. 146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1
26. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
27. Engineered Type-1 Regulatory T Cells as Cellular Therapy for Treatment of Immune Mediated Diseases
28. 271 - T-allo10 Infusion after αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD
29. Expression of chemokine receptor CX3CR1 in infants with respiratory syncytial virus bronchiolitis
30. Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization
31. 296 - Phase 1/1b Study of T-allo10 Infusion after HLA-Partially Matched αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Preliminary Results
32. Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy
33. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
34. A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis
35. Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics
36. Učinak montelukasta na regulacijske T-limfocite i imunoregulacijske citokine u djece s alergijskom astmom
37. Circulating early plasma cells with high TLR9 and low BAFF-receptor expression in a SLE patient before and after treatment
38. Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus
39. Multi-color phenotyping of FOXP3 and IL-7 receptor-alpha levels on human CD4+CD25high regulatory T cells
40. Conventional treatment modulates B cell TLR9 expresssion and IL-10 and BAFF production in systemic lupus erythematosus
41. Razlike u ekspresiji TLR9 i produkciji interleukina-10 i BAFF-a u novootkrivenih bolesnika sa sistemskim eritemskim lupusom tijekom liječenja klorokinom
42. Circulating B-cell activating factor levels' dependence on treatment in patients with systemic lupus erythematosus
43. Effect of chloroquine add-on therapy on TLR9 expression in systemic lupus erythematosus
44. Immunomodulatory therapy, B cells and autoimmune disease
45. Alternative to animal testing: new approaches in the development and control of biologicals
46. Modulation of Toll-like receptor 9 expression in systemic lupus erythematosus
47. Effect of steroid on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up
48. Extracellular expression of otherwise intracellular Toll-like receptors
49. Development of scientific institutions: example of knowledge transfer within the international Wellcome trust project
50. THE ROLE OF TOLL-LIKE RECEPTORS AND REGULATORY T CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.